Categories
+ DNA
+ Nanoparticle
+ Protein
- RNA
3' end analysis
Electrophoresis
Epitranscriptome
miRNA interference
miRNA-mRNA interaction
mRNA translation
qRT-PCR
Reverse transcription
RNA capping
RNA degradation
+ RNA detection
RNA extraction
RNA interference
RNA labeling
RNA localisation
RNA Modification
+ RNA purification
RNA sequencing
RNA splicing
RNA structure
RNA synthesis
RNA-protein interaction
Transcription
Transfection
Protocols in Past Issues

Analyzing (Re)Capping of mRNA Using Transcript Specific 5' End Sequencing

Dd Daniel del Valle Morales
DS Daniel R. Schoenberg
4378 Views
Oct 20, 2020
The 5′ cap is a ubiquitous feature of eukaryotic mRNAs. It is added in the nucleus onto newly synthesized pre-mRNA, and in the cytoplasm onto mRNAs after decapping or endonuclease cleavage. Cytoplasmic recapping can occur after loss of the cap at the native 5′ end, or downstream within the body of the mRNA. The identification and location of recapping events is key to understanding the functional consequences of this process. Here we present an approach that addresses this problem, using the Lexogen TeloPrime® cDNA synthesis kit to tag recapped 5′ ends. TeloPrime uses a proprietary DNA ligase to add a double stranded DNA oligonucleotide onto the 3′ end of cDNA while it is base paired with mRNA. Specificity for capped ends is obtained by the oligonucleotide having an unpaired C residue that base pairs weakly with m7G on the mRNA 5′ end. This is followed by PCR amplification of double-stranded cDNA using primers to the appended oligonucleotide and the mRNA of interest. The resulting products are gel purified and sequenced directly (if a single band) or cloned and sequenced. The sequence at the junction between the ligated oligonucleotide and the target mRNA provides the location of the cap on the corresponding transcript. This assay is applicable to all capped transcripts. It can be used with Sanger sequencing for small numbers of transcripts or adapted for use with Illumina library sequencing.

RNA Cap Methyltransferase Activity Assay

Jackson B. Trotman Jackson B. Trotman
DS Daniel R. Schoenberg
8533 Views
Mar 20, 2018
Methyltransferases that methylate the guanine-N7 position of the mRNA 5’ cap structure are ubiquitous among eukaryotes and commonly encoded by viruses. Here we provide a detailed protocol for the biochemical analysis of RNA cap methyltransferase activity of biological samples. This assay involves incubation of cap-methyltransferase-containing samples with a [32P]G-capped RNA substrate and S-adenosylmethionine (SAM) to produce RNAs with N7-methylated caps. The extent of cap methylation is then determined by P1 nuclease digestion, thin-layer chromatography (TLC), and phosphorimaging. The protocol described here includes additional steps for generating the [32P]G-capped RNA substrate and for preparing nuclear and cytoplasmic extracts from mammalian cells. This assay is also applicable to analyzing the cap methyltransferase activity of other biological samples, including recombinant protein preparations and fractions from analytical separations and immunoprecipitation/pulldown experiments.